Botox Alternative May Safely Smooth Forehead Lines

Reloxin is already approved outside US, but not all experts are convinced by new study

By Steven Reinberg
HealthDay Reporter

Related Encyclopedia • Amenorrhea • Amniocentesis • Amniocentesis and CVS • Anovulation More... Related Healthscout Videos Optimistic Healing Early Babies: How Soon is Too Soon? Aqua Lipo Cancer Detection More... Related Animations • Breast Reduction • Breast Self-Exam Video • Erectile Dysfunction • Facelift More... Related Drug Information • Actonel • Detrol LA • Diflucan • Ditropan XL More... Related News Articles • Focusing on School Could Prevent Teen Pregnancies • Low Vitamin D Tied to Estrogen Decline • Caring Through Sharing -- Life Changing Stories • Breast Cancer Pain Continues Years After Treatment More...

MONDAY, March 16 (HealthDay News) -- A new type of Botox drug called Reloxin appears safe and effective in reducing forehead wrinkles, a new study finds.

The use of Botox to reduce forehead wrinkles and frown lines has long been a mainstay of cosmetic medicine. The medication works by preventing face muscles from contracting, an effect that lasts for several months.

Text Continues Below

---

As an alternative to Botox, Reloxin is now approved in 23 countries outside the United States to smooth wrinkles, the researchers noted. The drug has also been used outside the United States for more than 15 years to treat neurological disorders.

One of the differences between Botox and Reloxin is that Reloxin has less protein in its formula, noted Dr. Kamran Jafri, from Jafri Craniofacial Plastic Surgery, New York City. Reloxin also contains fewer antigens, which cause the drug to break down more quickly, said Jafri, who was not involved in the new study.

"Theoretically, because Reloxin has less of a protein load the body will break it down at a slower rate. That means from a clinical perspective that it should last longer than Botox," he said. "However, some of the early trials are showing that Botox actually lasts longer than Reloxin."

Another difference between the drugs is that Reloxin defuses more in the tissue than Botox, Jafri said. "Botox typically defuses in about a one centimeter radius, Reloxin can go anywhere from one to three centimeters," he said. "That's a good thing for the forehead, where you can give fewer injections, but it's a bad thing for, say, crow's feet, where unless you are an experienced injector and you know the muscles very well, it could spread to other muscles and cause a droopy eyebrow or droopy eyelid," he explained.

In this phase III trial, Reloxin's wrinkle-smoothing effects lasted more than 13 months. And although the drug is still awaiting approval from the U.S. Food and Drug Administration, it could someday become a serious competitor to Botox, the researchers said.

Page:  1 | 2 | 3 | Next >>